Skip to content
Direct Journal

The Zimbabwean Government Rejects ‘Unbalanced’ US Health Aid Deal Due to Information Apprehensions

Health funding image
The offered American financial assistance would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

Zimbabwe has declined a significant American health deal valued at $367m (£272m) spanning five years over the United States' demand for sensitive biological samples.

This rejection was revealed after a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa deemed the deal was "lopsided".

An official spokesperson later stated that the US was seeking health data for scientific study and commercial purposes while was not willing to share the benefits from any future medical innovations.

"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has appealed for more talks to find a deal acceptable to both sides so the nation's critical HIV treatment initiative can be sustained.

Broader Background

This rejection follows a similar case in neighbouring Kenya, where a high court blocked a related health funding agreement after concerns were filed about the security of citizens' medical information.

Since returning to office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).

The agency had overseen aid for the US government, but Trump stated its expenditure was "wasteful" and his government was seeking government-to-government deals to enhance openness and accountability.

According to statements, Sixteen African countries have so far signed these new agreements, representing over $18.3bn in committed funds.

Details of the Declined Deal

The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".

"We believe this cooperation would have delivered significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," Tremont commented.

However, government spokesperson Nick Mangwana argued the proposed deal was "unequal".

"The proposal required Zimbabwe to surrender its genetic material and health information for a long time, without any corresponding guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that could result from that shared data," he stated.

"In essence, our nation would supply the basic resources for medical research without any certainty that the final treatments would be available to our people should a future pandemic arise."

National Interest and International Frameworks

He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining systems already set up via the global organization.

The spokesperson cited its Pandemic Benefit-Sharing scheme created to manage potential pandemics.

"This system is designed to guarantee that when a nation contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."

The government's concerns regarding the US deal "are not meant as hostility towards the US," he added.

"We welcome further dialogue with our US partners on how future co-operation might be designed in a manner that respects the sovereignty and dignity of each country."

Health Experts Reaction

Medical experts stated it acknowledged the government's concerns, but recommended that negotiations need to persist considering a large portion of the nation's Aids initiatives were funded by foreign aid.

"If specific concerns exist, including those involving data governance or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," the group commented.

The situation highlights the complex challenges between receiving much-needed foreign assistance and protecting a country's data in an increasingly interconnected world.

About the author

Morgan Berry

A technology strategist and writer with over a decade of experience in digital transformation and startup ecosystems.

Direct Journal

Type to search articles.